Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000488177 | SCV000532045 | benign | not provided | 2020-12-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000472657 | SCV000553806 | benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000488177 | SCV000575602 | uncertain significance | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000435288 | SCV000613886 | benign | not specified | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003343821 | SCV004061341 | likely benign | Inborn genetic diseases | 2023-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |